Hope Within Reach: Expanding Access to Life-Saving Blood Cancer Therapies
Bone marrow transplants and CAR T-cell therapy are life-saving treatments for various hematological malignancies and other diseases. However, their accessibility is limited by several factors, including the availability of specialized treatment centers, high costs, logistical challenges, and disparities in donor matching and insurance coverage. Significant efforts are underway to address these barriers and make these therapies more accessible to a wider range of patients.
In an interview with Targeted OncologyTM, Hannah Abrams, MD, fellow in hematology-oncology at Fred Hutch Cancer Center, discusses some the importance of increased accessibility and some of the advocacy work that is being done to make it possible.
Overall, a multi-faceted approach involving research, clinical practice changes, policy advocacy, financial support, and collaborative initiatives is crucial to enhance the accessibility of both bone marrow transplantation and CAR T-cell therapy, ensuring that more patients can benefit from these innovative treatments.
